Who invested in Antibacterial Resistance Leadership Group (ARLG)?
Antibacterial Resistance Leadership Group (ARLG)'s investors include National Institute of Allergy and Infectious Diseases.
Who invested in Antibacterial Resistance Leadership Group (ARLG)
Funding summaryUpdated 26 Oct 2026
$103Mraised across 1 round since 2019, from 1 source
- Latest round
- Grant, $103MDec 2019
- Investors
- 1
The rounds
- Dec 2019
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Antibacterial Resistance Leadership Group (ARLG)
How much has Antibacterial Resistance Leadership Group (ARLG) raised?
Antibacterial Resistance Leadership Group (ARLG) has raised $103M across 1 round since 2019.
When did Antibacterial Resistance Leadership Group (ARLG) last raise?
Antibacterial Resistance Leadership Group (ARLG)'s most recent round was a Grant of $103M in Dec 2019.
What was Antibacterial Resistance Leadership Group (ARLG)'s biggest round?
Its most recent round, $103M in Dec 2019, is also its largest on record.
Who backed Antibacterial Resistance Leadership Group (ARLG) first?
Antibacterial Resistance Leadership Group (ARLG)'s first round on record, in Dec 2019, was backed by National Institute of Allergy and Infectious Diseases.
What stage is Antibacterial Resistance Leadership Group (ARLG) at?
Antibacterial Resistance Leadership Group (ARLG)'s latest named round is a Grant, in Dec 2019.
Companies like Antibacterial Resistance Leadership Group (ARLG)
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.